"Rokotetutkimuskeskus on Tampereen yliopiston lääketieteen ja terveysteknologian tiedekunnan alaisuudessa toimiva erikoisyksikkö. Toteutamme tieteellisesti ja eettisesti korkeatasoisia, kliinisiä rokotetutkimuksia yhdessä rokotevalmistajien kanssa, sekä omia akateemisia tutkimushankkeita. Tavoitteemme on saada käyttöön uusia, entistä turvallisempia ja tehokkaampia rokotteita lapsille, nuorille ja aikuisille. Rokotetutkimuskeskusta johtaa professori Mika Rämet."

During the past decade, Oulu Vaccine Research Clinic conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 10 clinical trials were completed, i.e. on average, 111.1% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 5 clinical trials were completed. i.e. 166.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Oulu Vaccine Research Clinic" #1 sponsor was "Pfizer" with 7 trials, followed by "Merck Sharp & Dohme LLC" with 2 trials sponsored, "Janssen Vaccines & Prevention B.V." with 1 trials sponsored, "Novartis Vaccines" with 1 trials sponsored and "Takeda" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

According to Clinical.Site data, the most researched conditions in "Oulu Vaccine Research Clinic" are "Meningococcal Vaccine" (4 trials), "Pneumococcal Infections" (2 trials), "Clostridium Difficile Infection" (1 trials), "Hepatitis B Vaccines" (1 trials) and "Lower Respiratory Tract Disease" (1 trials). Many other conditions were trialed in "Oulu Vaccine Research Clinic" in a lesser frequency.

Most popular intervention types in "Oulu Vaccine Research Clinic" are "Biological" (13 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Saline" (3 trials), "rLP2086" (3 trials), "Adenovirus serotype 26 (Ad26)-based respiratory syncytial virus (RSV). preF" (1 trials) and "Bivalent rLP2086 Vaccine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Oulu Vaccine Research Clinic" are 13 trials for "All" genders.

Currently, there are NaN active trials in "Oulu Vaccine Research Clinic". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Oulu Vaccine Research Clinic, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Oulu Vaccine Research Clinic, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".